Slide 1 Evidence and Policy Gaps on ART at 500 CD4, TasP and PrEP. Why are we not scaling up the use of ART more aggressively? “A frank dialogue on the future of HIV treatment…
Evidence and Policy Gaps on ART at 500 CD4, TasP and PrEP Evidence and Policy Gaps on ART at 500 CD4, TasP and PrEP. Why are we not scaling up the use of ART more aggressively?…